Seems the justification for asking for a randomised study was the failure of two previous randomised studies that occured a decade ago with different treatment regimens and the fact that the FDA couldn't work out what an appropriate null hypothesis is - seems flimsy to me and I guess 9 of the ODAC committee agreed that the FDA were barking up the wrong tree. Cest la vie I suppose
Seeking Alpha hatchet job, page-117
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.005(0.46%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $3.714M | 3.421M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 25036 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 65679 | 20 |
View Market Depth
| Last trade - 14.18pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |